Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemia

Cancer

Volumn 78, Issue 11, 1996, Pages 2437-2442

  Gajjar, Amar ^a,b   Ribeiro, Raul C ^a,b   Mahmoud, Hazem H ^a,b,c   Sandlund, John T ^a,b   Liu, Qing ^a   Furman, Wayne L ^a,b   Santana, Victor M ^a,b   Crist, William M ^a,b   Rivera, Gaston K ^a,b   Pui, Ching Hon ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Midwest children'S' Cancer Center   (United States)

Author keywords

childhood acute lymphoblastic leukemia; risk factors; testicular leukemia; therapy

Indexed keywords

ANTIMETABOLITE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL; TESTIS BIOPSY; TESTIS DISEASE; TESTIS SIZE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, T-CELL; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 10544248163     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2437::AID-CNCR23>3.0.CO;2-0     Document Type: Article

References (27)

1. Hustu OH, Aur RJA. Extramedullary leukaemia. Clin Haematol 1978;7:313-37.
2. Pinkel D, Woo S. Prevention and treatment of meningeal leukemia in children. Blood 1994;84:355-66.
3. Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman WP, et al. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St. Jude Total Therapy Study X. Leukemia 1992;6:150-7.
4. Rivera GK, Raimondi SC, Hancock M, Behm FG, Pui C-H, Abromowitch M, et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991;337:61-6.
5. Evans WE, Rodman J, Relling MV, Crom WR, Rivera GK, Crist WM, et al. Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. Semin Hematol 1991;28:15-21.
6. Pui C-H, Relling MV, Behm FG, Hancock ML, Boyett IM, Raimondi SC, et al. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia 1995;9:1680-4.
7. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. Part I: introduction and design. Br J Cancer 1976;34:585-612.
8. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. Part II: analysis and examples. Br J Cancer 1977;35:1-39.
9. Cox DR, Hinkley DV. Theoretical statistics. New York, NY: Chapman and Hall, 1974:323-4.
10. Kalbfleish JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
11. Reaman G, Zeltzer P, Bleyer WA. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Study Group. J Clin Oncol 1985;3: 1513-21.
12. Pui C-H, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, et al. 11q23/MLL Rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994;12:909-15.
13. Santana VM, Dodge RK, Crist WM, Rivera GK, Look AT, Behm FG, et al. Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia. Leukemia 1990;4:87-90.
14. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. A uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia (ALL). J Clin Oncol 1996; 14:18-24.
15. Pui C-H. Childhood leukemias. N Engl J Med 1995;332:1618-30.
16. Kellie SJ, Pui C-H, Murphy SB. Childhood non-Hodgkin's lymphoma involving the testis: clinical features and treatment outcome. J Clin Oncol 1989;7:1066-70.
17. Dalle JH, Patte C, Michon J, Gentet JC, Schmitt C, Mechinaud F, et al. Curability without local treatment of testicular involvement in childhood B cell lymphoma/leukemia. Results of the SFOP LMB protocols. Proc Am Soc Clin Oncol March 1995;14:1290.
18. Eden OB, Lilleyman JS, Richard S. Testicular irradiation in childhood lymphoblastic leukaemia. Br J Haematol 1990;75: 496-8.
19. Bowman WP, Aur RJA, Hustu HO, Rivera G. Isolated testicular relapse in acute lymphocytic leukemia of childhood: categories and influence on survival. J Clin Oncol 1984;2: 924-9.
20. Ortega IJ, Javier G, Torán N. Testicular infiltrates in children with acute lymphoblastic leukemia: a prospective study. Med Pediatr Oncol 1984;12:386-93.
21. Kim TH, Hargreaves HK, Chan WC, Brynes RK, Alvarado C, Woodard J, et al. Sequential testicular biopsies in childhood acute lymphocytic leukemia. Cancer 1986;57:1038-41.
22. Miller DR, Leikin SL, Albo VC, Palmer NF, Sather HN, Hammond GD. The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. J Clin Oncol 1990;8:57-66.
23. Niemeyer CM, Gelber RD, Tarbell NJ, Donnelly M, Clavell LA, Blattner SR, et al. Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update). Blood 1991;78: 2514-9.
24. Abromowitch M, Ochs J, Pui C-H, Fairclough D, Murphy SB, Rivera GK. Efficacy of high-dose methotrexate in childhood acute lymphoblastic leukemia: analysis by contemporary risk classifications. Blood 1988;71:866-9.
25. Moe PJ, Siep M, Finne PH. Intermediate dose-methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Report on a national treatment program. Hematologia 1981; 14:2257-63.
26. Freeman AI, Weinberg V, Brecher ML, Jones B, Gliksman AS, Sinks LF, et al. Comparison of intermediate-dose methotrexate with cranial irradiation for the post induction treatment of acute lymphocytic leukemia in children. N Engl J Med 1983;308:477-84.
27. Freeman AI, Boyett JM, Glicksman AS, Brecher ML, Leventhal BG, Sinks LF, et al. Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten year follow-up. Med Pediatr Oncol. In press.